# OnCo record cervical (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/cervical/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "cervical" ;
  schema:name "Cervical cancer"@en ;
  schema:alternateName "CESC"@en, "TCGA-CESC"@en, "cervical squamous cell carcinoma and endocervical adenocarcinoma (TCGA CESC cohort)"@en ;
  schema:description "A cancer that could be eliminated by HPV vaccination and screening. For those who develop it, immunotherapy and a tissue-factor ADC have improved survival."@en ;
  schema:url <https://onco.cc/cancers/cervical/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cervical_cancer> ;
  owl:sameAs <http://www.wikidata.org/entity/Q160105> ;
  schema:citation <https://en.wikipedia.org/wiki/Cervical_cancer> ;
  onco:tag "gyn", "spike" ;
  onco:related <https://onco.cc/pairings/induction-chemo-then-crt/>, <https://onco.cc/pairings/io-plus-crt-cervical/>, <https://onco.cc/pairings/caution-mis-radical-hysterectomy/>, <https://onco.cc/pairings/radiation-plus-io/>, <https://onco.cc/roadmaps/early-detection-roadmap/>, <https://onco.cc/cancers/vaginal/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/til-therapy/>, <https://onco.cc/technologies/probiotics-treatment-diarrhoea/>, <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/colposcopy-excision/>, <https://onco.cc/technologies/precancer-ablation/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:targets <https://onco.cc/targets/tissue-factor/>, <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/vegf/>, <https://onco.cc/targets/ctla4/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/pdl1/> ;
  onco:companies <https://onco.cc/companies/color-health/>, <https://onco.cc/companies/mabwell-shanghai-bioscience/>, <https://onco.cc/companies/bio-thera-solutions/>, <https://onco.cc/companies/neonc-technologies/>, <https://onco.cc/companies/merck/>, <https://onco.cc/companies/roche-genentech/>, <https://onco.cc/companies/genmab/>, <https://onco.cc/companies/pfizer/>, <https://onco.cc/companies/akeso/>, <https://onco.cc/companies/regeneron/>, <https://onco.cc/companies/nrg-oncology/> ;
  onco:institutions <https://onco.cc/institutions/tikur-anbessa-hospital/>, <https://onco.cc/institutions/iarc/>, <https://onco.cc/institutions/cruk/>, <https://onco.cc/institutions/md-anderson/> ;
  onco:terms <https://onco.cc/terms/cin-hsil/>, <https://onco.cc/terms/cps/>, <https://onco.cc/terms/tumour-agnostic/> ;
  onco:trials <https://onco.cc/trials/mumbai-via-screening/>, <https://onco.cc/trials/nct07418749/>, <https://onco.cc/trials/nct05027776/>, <https://onco.cc/trials/nct07216703/>, <https://onco.cc/trials/nct04422366/>, <https://onco.cc/trials/nct07168200/>, <https://onco.cc/trials/nct06459180/>, <https://onco.cc/trials/nct06123884/>, <https://onco.cc/trials/nct05235516/>, <https://onco.cc/trials/nct06079671/>, <https://onco.cc/trials/nct06692166/>, <https://onco.cc/trials/nct04906993/> ;
  onco:people <https://onco.cc/people/jade-goody/> ;
  onco:journals <https://onco.cc/journals/international-journal-of-gynecological-cancer/>, <https://onco.cc/journals/journal-of-gynecologic-oncology/> ;
  onco:pipeline <https://onco.cc/drugs/sacituzumab-tirumotecan/>, <https://onco.cc/drugs/lifileucel/>, <https://onco.cc/drugs/shr-8068/>, <https://onco.cc/drugs/shr-a2102/>, <https://onco.cc/drugs/yl202/>, <https://onco.cc/drugs/hlx43/>, <https://onco.cc/drugs/gotistobart/>, <https://onco.cc/drugs/hmbd-001/>, <https://onco.cc/drugs/lorigerlimab/>, <https://onco.cc/drugs/vudalimab/>, <https://onco.cc/drugs/np137/>, <https://onco.cc/drugs/cadonilimab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/trials/senticol-iii/>, <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/precancer-ablation/>, <https://onco.cc/ideas/idea-single-dose-hpv-self-sampling-elimination/>, <https://onco.cc/ideas/idea-hpv-ctdna-cervical/>, <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/proton-therapy/> ;
  onco:standardOfCare <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/tisotumab-vedotin/>, <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/trials/ken-she/>, <https://onco.cc/technologies/hpv-testing/>, <https://onco.cc/technologies/precancer-ablation/>, <https://onco.cc/technologies/colposcopy-excision/>, <https://onco.cc/technologies/colposcopy-excision/>, <https://onco.cc/technologies/precancer-ablation/>, <https://onco.cc/terms/cin-hsil/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/trials/senticol-iii/>, <https://onco.cc/trials/lacc/>, <https://onco.cc/pairings/caution-mis-radical-hysterectomy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/trials/keynote-a18/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/trials/interlace/>, <https://onco.cc/pairings/induction-chemo-then-crt/>, <https://onco.cc/pairings/io-plus-crt-cervical/>, <https://onco.cc/trials/outback/>, <https://onco.cc/trials/keynote-826/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/trials/beatcc/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/trials/compassion-16/>, <https://onco.cc/drugs/cadonilimab/>, <https://onco.cc/drugs/tisotumab-vedotin/>, <https://onco.cc/trials/innovatv-301/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/trials/empower-cervical-1/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/trials/destiny-pantumor02/>, <https://onco.cc/drugs/sacituzumab-tirumotecan/>, <https://onco.cc/drugs/lifileucel/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/proton-therapy/> .